Endocannabinoid System & Trauma Sleep Research Insights
Pre-trauma insomnia and substance use are linked in trauma survivors, increasing risk for problematic alcohol and cannabis use. Early posttraumatic stress symptoms partially mediate this relationship. Addressing sleep disturbances may reduce substance…
Trauma-Focused Treatment and Cannabis Use in PTSD Care
Trauma-focused treatment PTSD cannabis use remains effective even with co-occurring substance use disorders. Cannabis use does not reduce the benefits of trauma-focused psychotherapy. This insight supports maintaining evidence-based PTSD care protocols.
Change My Mind
Your endocannabinoid system was already mediating pain, mood, and immune function before cannabis became trendy—the plant just happens to be one way to influence it. Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young…
Tuxedo Winnie the Pooh
“Cannabis is just a plant, can’t be medicine.” Right side fancy Pooh: “Actually, cannabinoids modulate the endocannabinoid system and demonstrate efficacy in peer-reviewed clinical trials for nausea, pain, and seizure…
One Does Not Simply
One does not simply explain the endocannabinoid system to a patient in under fifteen minutes. Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds | The Independent Evidence WatchDaily Digest 2026-03-08…
Cannabinoids for Children: Clinical Evidence Reviewed
Current cannabinoids pediatric safety evidence spans 276 studies covering plant-derived and pharmaceutical formulations for children under 18. This clinical review synthesizes safety and reported benefits from interventional trials and observational…
VER-01 Cannabis Extract: Phase 3 Trial for Chronic Back Pain
The VER-01 cannabis extract clinical trial evaluated 820 adults with chronic low back pain in a rigorous phase 3 study. Results demonstrated significant pain reduction and a favorable safety profile. This trial adds important clinical evidence for…
Endocannabinoid System: Cannabis for Chronic Pain Review
Cannabis-based products for chronic pain clinical evidence shows modest but measurable reductions in pain severity compared to placebo. The quality of evidence varies by THC-to-CBD ratio, product type, and delivery method. Patients and clinicians should…
Germany’s Post-CanG Import Surge Loses Steam as Q4 Growth Stalls
Germany cannabis import slowdown following legalization signals a plateau in market growth. This affects clinicians’ ability to source consistent cannabis products. Understanding these trends is vital for patient access and treatment planning.
Gov. Evers Highlights Risks of Federal Hemp Regulations in Wisconsin
Federal hemp regulations allowing delta-9 THC products to remain largely unregulated create patient safety concerns in Wisconsin. Clinicians face challenges due to unknown potency and contaminants in hemp products. Understanding federal hemp regulations…
